https://doi.org/10.1016/j.cell.2012.06.024
I
Ian R. Watson
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
161
Papers
10.7K
Citations
28
h-index
40
i10-index
Ian R. Watson is an academic researcher from McGill University Health Centre. The author has contributed to research in topics: Melanoma and MAPK Pathways & CAR-T cell therapy research & PARP inhibition in cancer therapy. The author has an h-index of 28, co-authored 137 publications.
ORCID: 0000-0002-6025-3080Papers by this author
worksA Landscape of Driver Mutations in Melanoma
2012 · Cell · 2,577 citations
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial
2023 · Nature Medicine · 385 citations
https://doi.org/10.1038/s41591-023-02453-x
Single-cell spatial immune landscapes of primary and metastatic brain tumours
2023 · Nature · 354 citations
https://doi.org/10.1038/s41586-022-05680-3
Tumor-associated B-cells induce tumor heterogeneity and therapy resistance
2017 · Nature Communications · 139 citations
https://doi.org/10.1038/s41467-017-00452-4
Suppression of Hypoxia-Inducible Factor 2α Restores p53 Activity via Hdm2 and Reverses Chemoresistance of Renal Carcinoma Cells
2009 · Cancer Research · 81 citations
https://doi.org/10.1158/0008-5472.can-09-1770
Ubiquitin and Ubiquitin-Like Modifications of the p53 Family
2006 · Neoplasia · 74 citations
https://doi.org/10.1593/neo.06439
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat